If so, and revenues won't be recognized until FDA approval, then SIGA has no interest in getting FDA approval unless Parsons reverses his earlier decision and/or lessens the payment to PIP. The Supremes have said Parson's needs to be reconsider based on law. It's only been since JANUARY 2013 since the Supremes stated such #$%$!!). In any case, SIGA can choose not to go forward for FDA approval and wait out the 10-years. It is as simple as that. If Parsons rules for $1 to PIP , which is what Mo' and some others think here (including me), then FDA pathway will be pursued by SIGA and additional sales will be generated. See...simple.